These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17681045)

  • 1. Peroxisome proliferator-activated receptors: new players in the field of reproduction.
    Toth B; Hornung D; Scholz C; Djalali S; Friese K; Jeschke U
    Am J Reprod Immunol; 2007 Sep; 58(3):289-310. PubMed ID: 17681045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
    Froment P; Gizard F; Defever D; Staels B; Dupont J; Monget P
    J Endocrinol; 2006 May; 189(2):199-209. PubMed ID: 16648288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A role of PPARgamma in reproduction?].
    Froment P; Gizard F; Staels B; Dupont J; Monget P
    Med Sci (Paris); 2005 May; 21(5):507-11. PubMed ID: 15885201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR ligands: are they potential agents for cardiovascular disorders?
    Balakumar P; Rose M; Singh M
    Pharmacology; 2007; 80(1):1-10. PubMed ID: 17496434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs and the placenta.
    Fournier T; Tsatsaris V; Handschuh K; Evain-Brion D
    Placenta; 2007; 28(2-3):65-76. PubMed ID: 16834993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure.
    Hewitt DP; Mark PJ; Waddell BJ
    Biol Reprod; 2006 Jan; 74(1):23-8. PubMed ID: 16135695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance.
    Patsouris D; Müller M; Kersten S
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1045-50. PubMed ID: 15535425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxisome proliferator-activated receptors and atherosclerosis].
    Jin N; Wang X
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective PPAR agonists for the treatment of type 2 diabetes.
    Nehlin JO; Mogensen JP; Petterson I; Jeppesen L; Fleckner J; Wulff EM; Sauerberg P
    Ann N Y Acad Sci; 2006 May; 1067():448-53. PubMed ID: 16804025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR and Pain.
    Maeda T; Kishioka S
    Int Rev Neurobiol; 2009; 85():165-77. PubMed ID: 19607969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage.
    Toth B; Bastug M; Mylonas I; Scholz C; Makovitzky J; Kunze S; Thaler C; Friese K; Jeschke U
    Acta Histochem; 2009; 111(4):372-8. PubMed ID: 19342081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear Receptor PPARs and magnesium].
    Fujii H
    Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [4-(2H-1,2,3-benzotriazol-2-yl)phenoxy]alkanoic acids as agonists of peroxisome proliferator-activated receptors (PPARs).
    Sparatore A; Godio C; Perrino E; Romeo S; Staels B; Fruchart JC; Crestani M
    Chem Biodivers; 2006 Apr; 3(4):385-95. PubMed ID: 17193275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Gross B; Staels B
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):687-710. PubMed ID: 18054742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.